OnKure Therapeutics, Inc. OKUR Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $192.11M+98.7% | $59.05M-46.7% | $70.33M+15.9% | $83.37M+132% | $96.66M+374% | ||
| $9.54M+76.6% | $5.67M+13.9% | $6.13M-7.6% | $5.26M-44.4% | $5.4M-54.2% | ||
| $197.48M+101% | $60.84M-46.2% | $71.53M-7.1% | $84.55M+8.4% | $98.17M+17.0% | ||
| $519K-43.9% | $618K-39.7% | $720K+1,120% | $821K+914% | $925K+807% | ||
| $288K-57.4% | $387K-49.7% | $485K+10.2% | $581K+17.8% | $676K+23.8% | ||
| $405K+272% | $273K+150% | $104K-29.3% | $116K-24.2% | $109K+70.3% | ||
| $198.69M+98.9% | $62.12M-45.9% | $72.84M-6.2% | $86.07M+9.3% | $99.88M+18.0% | ||
| $11.02M+370% | $1.43M-51.7% | $1.29M+444% | $2.38M+3,620% | $2.34M+247% | ||
| $409K-25.1% | $549K+2.4% | $567K+98.3% | $556K+68.0% | $546K+65.0% | ||
| $14.33M+63.1% | $5.92M-43.8% | $6.25M+92.3% | $7.6M+464% | $8.79M+212% | ||
| $409K-57.2% | $549K-49.4% | $687K+3.3% | $823K0.0% | $955K+5.3% | ||
| $12K— | $12K— | —— | —— | —— | ||
| $14.34M+55.3% | $5.93M-46.4% | $6.41M+76.6% | $7.9M+328% | $9.23M+172% | ||
| —— | —— | —— | —— | —— | ||
| $413.75M+58.3% | $270.42M+4.6% | $267.17M-13.8% | $264.2M-14.5% | $261.3M-15.2% | ||
| -$229.4M-34.4% | -$214.24M-38.5% | -$200.74M+14.9% | -$186.04M+19.9% | -$170.65M+24.8% | ||
| —— | —— | —— | —— | —— | ||
| $184.35M+103% | $56.18M-45.9% | $66.43M+149% | $78.17M+163% | $90.65M+181% | ||
| $198.69M+98.9% | $62.12M-45.9% | $72.84M-6.2% | $86.07M+9.3% | $99.88M+18.0% | ||
| $405K+272% | $273K+150% | $104K-29.3% | $116K-24.2% | $109K+70.3% | ||
| $288K-57.4% | $387K-49.7% | $485K+10.2% | $581K+17.8% | $676K+23.8% | ||
| $288K-57.4% | $387K-49.7% | $485K+10.2% | $581K+17.8% | $676K+23.8% | ||
| $405K+272% | $273K+150% | $104K-29.3% | $116K-24.2% | $109K+70.3% | ||
| $288K-57.4% | $387K-49.7% | $485K+10.2% | $581K+17.8% | $676K+23.8% | ||
| $405K+272% | $273K+150% | $104K-29.3% | $116K-24.2% | $109K+70.3% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $409K-57.2% | $549K-49.4% | $687K+3.3% | $823K0.0% | $955K+5.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are OnKure Therapeutics, Inc.'s total assets?
- OnKure Therapeutics, Inc. (OKUR) holds $198.7M in total assets, up 98.9% year over year.
- How much debt does OnKure Therapeutics, Inc. have?
- OnKure Therapeutics, Inc. carries $409.0K in total debt against $184.4M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does OnKure Therapeutics, Inc. have?
- OnKure Therapeutics, Inc. holds $192.1M in cash and equivalents.
- Can OnKure Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 13.78 — current assets exceed current liabilities.
- Where does OnKure Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from OnKure Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.